Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Sector news Drug Retailers - NEC
10/19DJAnthem To Launch Pharmacy Benefit Manager -- WSJ
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--3rd Update
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--2nd Update
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--2nd Update
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--Update
10/18DJAnthem Signs Five-Year Deal With CVS for Services to New Pharmacy-Benefit Man..
10/17 Amneal, Impax combine to tackle generic drug pricing pressure
10/16DJDentsply General Counsel Exits, Marking Fourth Resignation in Recent Weeks --..
10/16 U.S. top court to review antitrust claims against American Express
10/16 U.S. top court to review antitrust claims against American Express
10/10 Pharmacy benefit manager Express Scripts to buy eviCore for $3.6 billion
10/10DJEXPRESS SCRIPTS : to Buy Medical-Benefits Manager eviCore for $3.6 Billion
10/09DJMARKET SNAPSHOT : Stocks Close Lower In Thinly Traded Session; GE Has Biggest Dr..
10/06 Drug chains tumble on reports Amazon eyeing their pie
10/06 Drug chains tumble on reports Amazon eyeing their pie
09/28DJSINOPHARM : Rebuts Latest Negative Report
09/26 SHANGHAI PHARMACEUTICALS : CVC, others explore sale of drugmaker Alvogen - Bloom..
09/20DJWALGREENS BOOTS ALLIANCE : FTC Says Walgreens Can Buy Stores -- WSJ
09/20DJMakers Of Opioids Are Asked For Data -- WSJ
09/19DJStates Push Ahead With Investigation Into Opioid Painkillers
09/19 Walgreens gets regulatory nod for slimmed-down Rite Aid deal
09/19DJWALGREENS BOOTS ALLIANCE : Again Trims Deal for Rite Aid But Finally Gains Appro..
09/19DJWALGREENS BOOTS ALLIANCE : Again Trims Deal for Rite Aid But Finally Gains Appro..
09/19DJWALGREENS BOOTS ALLIANCE : Again Trims Deal for Rite Aid But Finally Gains Appro..
09/06DJGNC Picks Rite-Aid Stores Chief as New CEO
08/14 China's Fosun, Shanghai Pharma say bid for stake in U.S. drugmaker Arbor
08/09DJCVS HEALTH : Steps Further Onto Turf Of MDs -- WSJ
08/08DJCVS HEALTH : Moves Deeper Into Doctors' Turf
08/02DJPharMerica to Be Taken Private by KKR-Backed Company in $1.4 Billion Deal
08/02DJWALGREENS BOOTS ALLIANCE : Theranos Low on Cash After Settlement -- WSJ
08/01DJWALGREENS BOOTS ALLIANCE : Theranos Low on Cash After Settlement With Walgreens
07/26DJMCKESSON : Shareholders Reject Executive Compensation Packages
07/26 ANTHEM : Express Scripts says any new Anthem contract would be unfavorable
07/22DJCARDINAL HEALTH : Looks to Scale Back in China -- WSJ
07/21DJCARDINAL HEALTH : Exploring Options for China Unit -- Update
07/21DJCARDINAL HEALTH : Exploring Options for China Unit
07/10 MCKESSON : Teamsters urge McKesson shareholders to vote against CEO pay
06/30DJDrug Stores Scrap Merger -- WSJ
06/30DJWHAT'S NEWS : Business & Finance -- WSJ
06/29DJWalgreens Trims Rite Aid Deal After Antitrust Concerns -- 4th Update
06/29DJWalgreens Scores Deal With Purchase of Rite Aid Stores
06/29DJWalgreens Trims Rite Aid Deal After Antitrust Concerns -- 4th Update
06/29DJFred's Stock Takes a Hit After Walgreens-Rite Aid End Merger Plan
06/29DJWalgreens Trims Rite Aid Deal After Antitrust Concerns -- 3rd Update
06/29DJWalgreens Trims Rite Aid Deal After Antitrust Concerns -- 3rd Update
06/29DJMARKET SNAPSHOT : Dow, S&P 500 Look To Ride Bank Rally, But Tech Weakness May We..
06/29DJWalgreens Trims Rite Aid Deal After Antitrust Concerns -- 2nd Update
06/29DJWalgreens Ends $9.4 Billion Rite Aid Deal Outright, to Buy Some Rite Aid Stor..
06/29DJWALGREENS BOOTS ALLIANCE : Rite Aid End $9.4 Billion Merger; to Buy Half of Rite..
06/22DJWALGREENS BOOTS ALLIANCE : Theranos, Walgreens to Settle -- WSJ
Financials ($)
Sales 2017 184 B
EBIT 2017 10 051 M
Net income 2017 5 266 M
Debt 2017 24 750 M
Yield 2017 2,55%
P/E ratio 2017 15,12
P/E ratio 2018 13,14
EV / Sales 2017 0,56x
EV / Sales 2018 0,53x
Capitalization 77 757 M